Hi-Clearance (1788) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hi-Clearance (1788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$106.14 Million ≈ $3.34 Million USD) by net assets (NT$2.96 Billion ≈ $93.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Hi-Clearance to measure how many days the company can operate on defensive assets alone.
Hi-Clearance - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Hi-Clearance's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hi-Clearance Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hi-Clearance ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Consumer Portfolio Services Inc
NASDAQ:CPSS
|
0.276x |
|
Korea Real Estate Investment & Trust Co Ltd
KO:034830
|
-0.030x |
|
H&R GmbH & Co. KGaA
XETRA:2HRA
|
0.054x |
|
Acsion Ltd
JSE:ACS
|
0.034x |
|
Honghua Group Limited
F:4HB
|
0.011x |
|
Spurcorp
JSE:SUR
|
0.257x |
|
Intai Technology
TWO:4163
|
0.039x |
|
NELCO Limited
NSE:NELCO
|
0.086x |
Annual Cash Flow Conversion Efficiency for Hi-Clearance (2015–2024)
The table below shows the annual cash flow conversion efficiency of Hi-Clearance from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Hi-Clearance stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.00 Billion ≈ $94.58 Million |
NT$510.12 Million ≈ $16.07 Million |
0.170x | +16.97% |
| 2023-12-31 | NT$2.98 Billion ≈ $94.01 Million |
NT$433.49 Million ≈ $13.66 Million |
0.145x | -12.09% |
| 2022-12-31 | NT$2.44 Billion ≈ $76.86 Million |
NT$403.16 Million ≈ $12.70 Million |
0.165x | +32.30% |
| 2021-12-31 | NT$2.30 Billion ≈ $72.58 Million |
NT$287.79 Million ≈ $9.07 Million |
0.125x | -39.13% |
| 2020-12-31 | NT$2.01 Billion ≈ $63.42 Million |
NT$413.16 Million ≈ $13.02 Million |
0.205x | +42.69% |
| 2019-12-31 | NT$1.78 Billion ≈ $56.22 Million |
NT$256.67 Million ≈ $8.09 Million |
0.144x | -24.88% |
| 2018-12-31 | NT$1.64 Billion ≈ $51.70 Million |
NT$314.23 Million ≈ $9.90 Million |
0.191x | +28.21% |
| 2017-12-31 | NT$1.63 Billion ≈ $51.20 Million |
NT$242.70 Million ≈ $7.65 Million |
0.149x | -29.06% |
| 2016-12-31 | NT$1.56 Billion ≈ $49.09 Million |
NT$328.02 Million ≈ $10.33 Million |
0.211x | +549.74% |
| 2015-12-31 | NT$1.53 Billion ≈ $48.08 Million |
NT$49.45 Million ≈ $1.56 Million |
0.032x | -- |
About Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more